Anita Nelsen is a pharmaceutical industry professional with more than 25 years of experience in drug discovery and development in global pharmaceutical and contract research organizations.
As President of Clinical Trial Operations, Anita is responsible for strategy, development and execution of CTO including Project Management, Study Start-Up, Feasibility, Site Engagement, Clinical Operations, Patient Recruiting and Engagement and Clinical Trial Services and Technology.
Prior to joining Allucent, Anita served as Executive Vice President of Translational Medicine at Parexel International, where she led a diverse P&L including global early phase clinical unit operations, clinical pharmacology, modeling and simulation and biomarker and genomic medicine services, the latter a group which she founded shortly after joining Parexel in 2015. Previously, Anita also built and operated GlaxoSmithKline’s global human biological sample repository and served as an advisor to global project teams on the application of biomarker and genomic capabilities to facilitate the development and commercialization of medicines across all phases and in a wide range of therapeutic areas. Anita has authored/co-authored more than 30 peer-reviewed articles and many abstracts and presentations.